AstraZeneca Pharma India (ASTRAZEN) Stock Overview

AstraZeneca Pharma India Limited, a biopharmaceutical company, engages in manufacturing, distributing, and marketing of pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brand names; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brand names. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

ASTRAZEN Stock Information

Symbol

ASTRAZEN

Address

Manyata Embassy Business ParkBengaluru, 560045India

Founded

Trading hours

Website

https://www.astrazeneca.in

Country

🇮🇳 India

Phone Number

91 80 6774 8000

AstraZeneca Pharma India (ASTRAZEN) Price Chart

AstraZeneca Pharma India Overview: Key Details and Summary

Stock data	2023	Change
Price	$79.12	N/A
Market Cap	$1.98B	N/A
Shares Outstanding	25.00M	0.00%
Employees	947.00	N/A
Shareholder Equity	5.89B	15.12%

Valuation	2023	Change
P/E Ratio	1.99	N/A
P/S Ratio	16.54	N/A
P/B Ratio	0.34	N/A

Growth	2023	Change
Return on Equity	0.0020	N/A

Earnings	2023	Change
Revenue	$119.56M	N/A
Earnings	$11.84M	N/A
EPS	39.70	N/A
Earnings Yield	0.5018	N/A
Gross Margin	0.576	N/A
Operating Margin	0.1484	N/A
Net income margin	0.099	N/A

Financial Strength	2023	Change
Total Assets	$117.40M	N/A
Total Debt	$859.46K	N/A
Cash on Hand	$60.92M	N/A
Debt to Equity	0.0080	-0.29%
Cash to Debt	$70.88	32.77%
Current Ratio	$2.18	2.58%